Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Scott Berry
Cetuximab Plus Irinotecan Versus Panitumumab in Patients With Refractory Metastatic Colorectal Cancer in Ontario, Canada
International Journal of Cancer
Cancer Research
Oncology
The Randomized Embedded Multifactorial Adaptive Platform for Community-Acquired Pneumonia (REMAP-CAP) Study: Rationale and Design
Annals of the American Thoracic Society
Pulmonary
Respiratory Medicine
Related publications
Randomized, Phase II Study of the Insulin-Like Growth Factor-1 Receptor Inhibitor IMC-A12, With or Without Cetuximab, in Patients With Cetuximab- Or Panitumumab-Refractory Metastatic Colorectal Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Health-Related Quality of Life and Colorectal Cancer-Specific Symptoms in Patients With Chemotherapy-Refractory Metastatic Disease Treated With Panitumumab
International Journal of Colorectal Disease
Gastroenterology
P16 Hypermethylation and KRAS Mutation Are Independent Predictors of Cetuximab Plus FOLFIRI Chemotherapy in Patients With Metastatic Colorectal Cancer
Cancer Research and Treatment
Cancer Research
Oncology
Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-Line Cetuximab and Irinotecan
JAMA Oncology
Cancer Research
Oncology
Magnetic Resonance Imaging as an Early Indicator of Clinical Outcome in Patients With Metastatic Colorectal Carcinoma Treated With Cetuximab or Panitumumab
Clinical Colorectal Cancer
Oncology
Gastroenterology
Comparison of EORTC Criteria and PERCIST for PET/CT Response Evaluation of Patients With Metastatic Colorectal Cancer Treated With Irinotecan and Cetuximab
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
PTEN Loss of Expression Predicts Cetuximab Efficacy in Metastatic Colorectal Cancer Patients
British Journal of Cancer
Cancer Research
Oncology
Cetuximab in First Line Treatment of Metastatic Colorectal Cancer
Farmeconomia. Health economics and therapeutic pathways
FOLFIRI Plus Panitumumab in the Treatment of Wild-Type KRAS and Wild-Type NRAS Metastatic Colorectal Cancer
World Journal of Surgical Oncology
Surgery
Oncology
